|
"lai hsin wen"的相關文件
顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2016-10 |
Fluoxetine regulates cell growth inhibition of interferon-alpha
|
Lin, Yu-Min; Yu, Bu-Chin; Chiu, Wen-Tai; Sun, Hung-Yu; Chien, Yu-Chieh; Su, Hui-Chen; Yen, Shu-Yang; Lai, Hsin-Wen; Bai, Chyi-Huey; Young, Kung-Chia; Tsao, Chiung-Wen |
| 嘉南藥理大學 |
2016-10 |
Fluoxetine regulates cell growth inhibition of interferon-alpha
|
Lin, Yu-Min; Yu, Bu-Chin; Chiu, Wen-Tai; Sun, Hung-Yu; Chien, Yu-Chieh; Su, Hui-Chen; Yen, Shu-Yang; Lai, Hsin-Wen; Bai, Chyi-Huey; Young, Kung-Chia; Tsao, Chiung-Wen |
| 國立成功大學 |
2014-10 |
Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPAR beta/gamma-dependent pathways
|
Young, Kung-Chia; Bai, Chyi-Huey; Su, Hui-Chen; Tsai, Pei-Ju; Pu, Chien-Yu; Liao, Chao-Sheng; Lin, Yu-Min; Lai, Hsin-Wen; Chong, Lee-Won; Tsai, Yau-Sheng; Tsao, Chiung-Wen |
| 臺北醫學大學 |
2014 |
Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPAR beta/gamma-dependent pathways
|
Young, Kung-Chia;Bai, Chyi-Huey;Su, Hui-Chen;Tsai, Pei-Ju;Pu, Chien-Yu;Liao, Chao-Sheng;Lin, Yu-Min;Lai, Hsin-Wen;Chong, Lee-Won;Tsai, Yau-Sheng;Tsao, Chiung-Wen |
| 國立成功大學 |
2014 |
Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN
|
Lin, Chiou-Feng; Young, Kung-Chia; Bai, Chyi-Huey; Yu, Bu-Chin; Ma, Ching-Ting; Chien, Yu-Chieh; Chiang, Chiu-Ling; Liao, Chao-Sheng; Lai, Hsin-Wen; Tsao, Chiung-Wen |
| 國立成功大學 |
2013-12 |
Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog- deficient RAW264.7 cells
|
Lin, Chiou-Feng; Young, Kung-Chia; Bai, Chyi-Huey; Yu, Bu-Chin; Ma, Ching-Ting; Chien, Yu-Chieh; Su, Hui-Chen; Wang, Hue-Yu; Liao, Chao-Sheng; Lai, Hsin-Wen; Tsao, Chiung-Wen |
| 國立臺灣大學 |
2009 |
Ethnic-Specific Prevalence of Hepatitis B/C Virus Infection in Pin-Jen, Taiwan
|
賴欣汶; 熊惠英; 戴政; 張煥禎; 陳秀熙; LAI, HSIN-WEN; HSIUNG, HUI-YIN; TAI, JOHN JEN; CHANG, HUAN-CHENG; CHEN, TONY HSIU-HIS |
顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目
|
